Amy W. Schulman, Director, 10% Owner at SQZ Biotechnologies Co (SQZ), bought 3,700 shares at $10.88 ($40K) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Open-market purchase of $40k SQZ by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.88 | 1,850 | $20K | 49.9% |
| 2 | $10.94 | 1,850 | $20K | 50.1% |
| Total | $10.91 avg | 3,700 | $40K | 100% |
| Filing → |
| ALNY | SELL | 2024-06-27 | $2.0M | — | Filing → |
| ALNY | SELL | 2024-05-31 | $6.4M | — | Filing → |
| HCII | BUY | 2021-04-14 | $0 | — | Filing → |